Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2025	Dec. 31, 2024
Assets:
Cash and cash equivalents	$ 27,603	$ 24,654
Investments in securities:
Fixed maturity securities, available-for-sale, at fair value (amortized cost: March 31, 2025: $117,723; December 31, 2024: $112,588)	118,329	112,972
Equity securities, at fair value (cost: March 31, 2025: $23,854; December 31, 2024: $25,980)	34,589	39,893
Short-term investments	54,141	59,101
Other investments	20,123	20,578
Total investments	227,182	232,544
Premiums and fees receivable	15,691	16,054
Accrued interest and dividends	1,580	1,469
Prepaid expenses and other receivables	7,817	7,033
Property, net	28,311	27,935
Goodwill and other intangible assets, net	14,797	15,071
Lease assets	8,126	6,156
Other assets	2,674	2,655
Total Assets	333,781	333,571
Liabilities:
Reserve for claims	36,997	37,060
Accounts payable and accrued liabilities	28,683	34,011
Lease liabilities	8,374	6,356
Current income taxes payable	2,374	276
Deferred income taxes, net	2,941	4,095
Total liabilities	79,369	81,798
Commitments and Contingencies	0	0
Stockholders' Equity:
Preferred stock (1,000 authorized shares; no shares issued)	0	0
Common stock – no par value (10,000 authorized shares; 1,886 shares issued and outstanding as of March 31, 2025 and December 31, 2024, respectively, excluding in each period 292 shares of common stock held by the Company)	0	0
Retained earnings	253,827	251,418
Accumulated other comprehensive income	585	355
Total stockholders' equity	254,412	251,773
Total Liabilities and Stockholders’ Equity	$ 333,781	$ 333,571